ATHE - Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today? | Benzinga
Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's Disease Conference 2023.
The presentation demonstrated that ATH434 treatment improved motor performance and general function in monkeys with experimentally induced Parkinson's disease.
The favorable impact on Parkinson's symptoms was associated with lower iron levels in ...